RxDoctor Payments Data

John Jessup, NP

Adult Health · Syracuse, NYNPI 1649266800

Payments from drug & device makers

$2,071in general payments, 2019–2025

Across 150 payments — averaging $13.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$775
  • Amgen$372
  • AstraZeneca$220
  • Boehringer Ingelheim$129
  • Johnson & Johnson$88
  • Merck$87
  • plus $400 from 10 others

What the payments were for

  • Food & beverage$2,065100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,071 in reported general payments places this provider in the 80th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$71,297
Medicare patients
422
Services billed
1,499

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban326$481,113
JardianceEmpagliflozin141$201,061
Repatha SureclickEvolocumab126$150,582
XareltoRivaroxaban87$132,007
EntrestoSacubitril/Valsartan77$116,750
Praluent PenAlirocumab26$29,772
FarxigaDapagliflozin Propanediol18$23,689
MultaqDronedarone Hcl15$20,720
Ezetimibe387$9,048
Metoprolol Succinate295$5,291
Rosuvastatin Calcium344$4,795
Atorvastatin Calcium439$4,362
Losartan Potassium193$2,036
Carvedilol225$1,935
Potassium Chloride58$1,690

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$57$481,113326 claims
Boehringer IngelheimJardiance$129$201,061141 claims
Johnson & JohnsonXarelto$88$132,00787 claims
NovartisEntresto$775$116,75077 claims
AstraZenecaFarxiga$220$23,68918 claims
Sanofi-aventis U.S. LLCMultaq$28$20,72015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,828 adult health providers in New York.

Other adult health in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →